Read More Pharma Industry News bluebird bio unveils US commercial strategy for LYFGENIA gene therapy bluebird bio, Inc., a pioneer in the biotechnology industry, has announced the U.S. commercial infrastructure for LYFGENIA (lovotibeglogene… byPallavi MadhirajuDecember 9, 2023